Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease

American Journal of the Medical Sciences

Volumn 345, Issue 6, 2013, Pages 440-445

  Pelegrino, Nilva R G ^a   Tanni, Suzana E ^a   Amaral, Renata A F ^a   Angeleli, Aparecida Y O ^a   Correa, Camila ^a   Godoy, Irma ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Biomarkers; COPD; Induced sputum; Smoking; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; BODY COMPOSITION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FLOW VOLUME CURVE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFLAMMATION; SMOKING; SPIROMETRY; SPUTUM LEVEL;

EID: 84878462630     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31825f32a7     Document Type: Conference Paper

References (31)

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary-updated 2011. Available at: www.goldcopd.org. Accessed June 25, 2012.
2. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008; 31:1334-56.
3. Saetta M, Baraldo S, Corbino L, et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:711-7.
4. Hodge G, Nairn J, Holmes M, et al. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects. Clin Exp Immunol 2007;150:22-9.
5. Vernooy JH, Küçükaycan M, Jacobs JA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease - soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002;166:1218-24.
6. Higashimoto Y, Iwata T, Okada M, et al. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med 2009;103:1231-8.
7. He Z, Chen Y, Chen P, et al. Local inflammation occurs before systemic inflammation in patients with COPD. Respirology 2010;15: 478-84.
8. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-34.
9. Standardization of spirometry - 1987 update. American Thoracic Society Statement. Am Rev Respir Dis 1987;136:1285-98.
10. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis - part I: review of principles and methods. Clin Nutr 2004;23: 1430-3.
11. Kyle UG, Genton L, Karsegard L, et al. Single prediction equation for bioelectrical impedance analysis in adults aged 20-94 years. Nutrition 2001;17:248-53.
12. Kyle UG, Pichard C, Rochat T, et al. New bioelectrical impedance formula for patients with respiratory insufficiency: comparison to dualenergy X-ray absorptiometry. Eur Respir J 1998;12:960-6.
13. Schols AM, Soeters PB, Dingemans AM, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993;147:1151-6.
14. Popov TA, Pizzichini MM, Pizzichini E, et al. Some technical factors influencing the induction of sputum for cell analysis. Eur Respir J 1995; 8:559-65.
15. Pizzichini E, Pizzichini MM, Leigh R, et al. Safety of sputum induction. Eur Respir J 2002;20:9s-18s.
16. Lumley T, Diehr P, Emerson S, et al. The importance of the normality assumption in large public health data sets. Annu Rev Public Health 2002;23:151-69.
17. Higashimoto Y, Yamagata Y, Taya S, et al. Systemic inflammation in chronic obstructive pulmonary disease and asthma: similarities and differences. Respirology 2008;13:128-33.
18. Wouters EFM, Reynaert NL, Dentener MA, et al. Systemic and local inflammation in asthma and chronic obstructive pulmonary disease - is there a connection? Proc Am Thorac Soc 2009;6:638-47.
19. Keatings VM, Cave SJ, Henry MJ, et al. A polymorphism in the tumor necrosis factor-a gene promoter region may predispose to a poor prognosis in COPD. Chest 2000;118:971-5.
20. Gamble E, Grootendorst DC, Hattotuwa K, et al. Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis. Eur Respir J 2007;30:467-71.
21. Barceló B, Pons J, Fuster A, et al. Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease. Clin Exp Immunol 2006;145:474-9.
22. Ogawa Y, Duru EA, Ameredes BT. Role of IL-10 in the resolution of airway inflammation. Curr Mol Med 2008;8:437-45.
23. Karadag F, Kirdar S, Karul AB, et al. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med 2008;19:104-8.
24. Pinto-Plata VM, Müllerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006; 61:23-8.
25. de Torres JP, Cordoba-Lanus E, López-Aguilar C, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006;27:902-7.
26. Godoy I, Campana AO, Geraldo RR, et al. Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients. Eur Respir J 2003;22:920-5.
27. Bucchioni E, Kharitonov SA, Allegra L, et al. High levels of interleukin- 6 in the exhaled breath condensate of patients with COPD. Respir Med 2003;97:1299-302.
28. Dentener MA, Louis R, Cloots RH, et al. Differences in local versus systemic TNF-a production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNFa release. Thorax 2006;61:478-84.
29. Yamamoto C, Yoneda T, Yoshikawa M, et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 1997;112:505-10.
30. Paone G, Conti V, Vestri A, et al. Analysis of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients. Dis Markers 2011;31:91-100.
31. Keatings VM, Collins PD, Scott D, et al. Differences in interleukin-8 and tumor necrosis factor-a in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-4.